Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 006333
Company: CENT PHARMS
Company: CENT PHARMS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
SYNOPHYLATE | THEOPHYLLINE SODIUM GLYCINATE | EQ 165MG BASE/15ML | ELIXIR;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
10/17/1947 | ORIG-1 | Approval | UNKNOWN |
Label is not available on this site. |